Showing results (301-310 of 450) with videos related to
Sort By:
Pageof 45
Transplantation|September 1, 1989
Reversible pancytopenia following OKT3. Use in the context of multidrug immunosuppression for kidney allograftingG W Burke, G M Vercellotti, R L Simmons, et al.Archives of Surgery (Chicago, Ill. : 1960)|November 1, 1988
Endotoxin modulation of hepatocyte secretory and cellular protein synthesis is mediated by Kupffer cellsM A West, T R Billiar, J E Mazuski, et al.Nephron|January 1, 1976
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administrationT J Buselmeier, R L Simmons, J S Najarian, et al.Journal of Leukocyte Biology|April 1, 1990
Hepatocyte modulation of Kupffer cell prostaglandin E2 production in vitroT R Billiar, T W Lysz, R D Curran, et al.Annals of Surgery|October 1, 1978
The relationship between transfusion and hypoxemia in combat casualtiesJ A Collins, P M James, C E Bredenberg, et al.Medicine|July 1, 1980
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantationP K Peterson, H H Balfour, S C Marker, et al.Annals of Surgery|April 1, 1985
Modulation of hepatocyte protein synthesis by endotoxin-activated Kupffer cells. III. Evidence for the role of a monokine similar to but not identical with interleukin-1G A Keller, M A West, J T Harty, et al.Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1988
Direct effects of endotoxin on hepatocytes. Synthesis of a specific secretory proteinJ E Mazuski, J L Platt, M A West, et al.American Journal of Surgery|November 1, 1987
Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients. Data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprineT W Frick, D S Fryd, D E Sutherland, et al.Geriatrics|September 1, 1976
Kidney transplants in patients over 50C M Kjellstrand, J R Shideman, R E Lynch, et al.Pageof 45